Jazz Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell JAZZ and other ETFs, options, and stocks.About JAZZ
Jazz Pharmaceuticals Plc operates as a biopharmaceutical company, which focuses on the identification, development, and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain, and psychiatry. Its product portfolio includes: Xyrem, Xywav, Epidolex, Zepzelca, Rylaze, Vyxeos, and Defitelio.
JAZZ Key Statistics
Stock Snapshot
As of today, Jazz Pharmaceuticals(JAZZ) shares are valued at $245.80. The company's market cap stands at 15.96B, with a P/E ratio of 16.95.
During the trading session on 2026-09-13, Jazz Pharmaceuticals(JAZZ) shares reached a daily high of $246.69 and a low of $244.04. At a current price of $245.80, the stock is +0.7% higher than the low and still -0.4% under the high.
Trading volume for Jazz Pharmaceuticals(JAZZ) stock has reached 422.41K, versus its average volume of 781.71K.
The stock's 52-week range extends from a low of $123.88 to a high of $266.38.
The stock's 52-week range extends from a low of $123.88 to a high of $266.38.
JAZZ News
...
UBS raised the firm’s price target on Jazz Pharmaceuticals (JAZZ) to $337 from $315 and keeps a Buy rating on the shares. Jazz’s post-GEA approval of Ziihera su...
Analyst ratings
86%
of 22 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.